Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2333 (LINC02333) is a member of the long intergenic non-coding RNA (lincRNA) class, which consists of RNA molecules longer than 200 nucleotides that are transcribed from genomic regions not overlapping protein-coding genes[1][3]. LincRNAs, including LINC02333, generally act as regulators of gene expression, functioning through mechanisms such as chromatin modification, modulation of transcriptional activity, and organization of nuclear architecture. Although only a small fraction of annotated lincRNAs have had their functions directly characterized, these RNAs are recognized as important modulators of cellular function and may play tissue-specific or disease-relevant roles. However, as of current evidence, LINC02333 itself is not a receptor, enzyme, transporter, or recognized direct therapeutic target, and no drugs are currently known to interact with it[1][3].
Not applicable (no known direct drug targeting; lincRNAs act mainly at the level of gene regulation and chromatin state modulation[3])
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2333 (LINC02333).